Familial hypercholesterolaemia in children

British Journal of Cardiology

Volumn 13, Issue 3, 2006, Pages 191-194

  Nicholls, D Paul ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Children; Familial hypercholesterolaemia; Genetic testing; Statins

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; EZETIMIBE; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPANTIL MICRO 67; LOW DENSITY LIPOPROTEIN RECEPTOR; PRAVASTATIN; RESIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHILD; CHILDHOOD DISEASE; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; GENETIC CODE; GENETIC SCREENING; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MEDICAL DECISION MAKING; MUTATIONAL ANALYSIS; PREGNANCY; PROGNOSIS; PROTEIN DEGRADATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SUDDEN DEATH; TREATMENT PLANNING; UNITED KINGDOM; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

EID: 33745469241     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Betteridge DJ, Broome K, Durrington PN et al. Risk of fatal coronary artery disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991; 303:893-6.
2. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999;142:105-15.
3. Laing SP, Swerdlow AJ, Slater SD et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:459-65.
4. Tunstall-Pedoe H, Woodward M, Tavendale R et al. Comparison of the prediction by 27 different factors of coronary artery disease and death in men and women of the Scottish heart health study: cohort study. BMJ 1997;313:722-9.
5. Goldstein JL, Brown MS. Familial hypercholesterolaemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Nat Acad Sci USA 1973;70:2804-08.
6. Graham CA, McIlhatton BP, Kirk CW et al. Genetic screening protocol for familial hypercholesterolaemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis 2005;182:331-40.
7. Tybjaerg-Hansen A, Humphries SE. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis 1992;96:91-107.
8. Kachadurian AK. The inheritance of essential familial hypercholesterolemia. Am J Med 1964;37:402-07.
9. Gagne C, Bays HE, Weiss SR et al. Ezetimibe Study Group. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002;90: 1084-91.
10. Thompson GR, Miller JP, Breslow JL, Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. BMJ 1985;295:1671-3.
11. Bilheimer DW, Goldstein JW, Grundy S et al. Liver transplantation to provide low-density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984;311:1658-62.
12. Grossman M, Raper SE, Kozarsky K et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet 1994;6:335-41.
13. Christensen B, Glueck C, Kwiterovich P et al. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the prevlence study of the Lipd Research Clinics Program. Pediat Res 1980;14:194-202.
14. Ward AJ, O'Kane M, Nicholls DP et al. A novel single base deletion in the LDLR gene (211 deIG): effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, ApoE and ApoB gene. Atherosclerosis 1996;120:83-91.
15. Marteau T, Senior V, Humphries SE et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet 2004;128A:285-93.
16. Sorensen KE, Celemajer DS, Georgakopoulos D et al. Impairment of endothelium-dependent dilation is an early event in children with famiial hypercholesterolemia and is related to the Lipoprotein (a) level. J Clin Invest 1994;93:50-5.
17. De Jongh S, Lilien MR, Op't Roodt J et al. Early statin therapy restores endothelial function in children with familial hypercholesterolaemia. J Am Coll Cardiol 2002;40:2117-21.
18. Wiegman A, de Groot E, Hutten BA et al. Arterial intima-media thickness in childhood. A study in familial hypercholesterolaemia heterozgotes and their siblings. Lancet 2004;363:369-70.
19. Greene O, Durrington P. Clinical management of children and young adults with heterozygous familial hypercholesterolaemia in the UK. J Roy Soc Med 2004;97:226-9.
20. Neil HAW, Seagroatt V, Betteridge DJ et al. Established and emerging-coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart 2004;90:1431-7.
21. Maron BJ, Shirani J, Poliac LC et al. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles. JAMA 1996;276:199-204.
22. Knipscheer HC, Boelen CC, Kastelein JJ et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996;39:867-71.
23. Lambert M, Lupien PJ, Gagne C et al. Canadian Lovastatin in Children Study Group. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 1996;97:619-28.
24. Stein EA, Illingworth DR, Kwiterovich PO Jr et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281; 137-44.
25. de Jongh S, Ose L, Szamosi T et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002;106: 2231-7.
26. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidaemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143:74-80.